Sorafenib Terminated Phase 3 Trials for Hepatocellular,Carcinoma / Liver Cell Carcinoma Treatment

IndicationsStatusPurposePhase
TerminatedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT02460991A Study of ONCO-DOX in Locally Advanced Hepatocellular Carcinoma
NCT01887717Efficacy Evaluation of TheraSphere to Treat Inoperable Liver Cancer With Blockage of the Portal Vein
NCT00699374Study Of Sunitinib Malate Versus Sorafenib In Patients With Inoperable Liver Cancer